+41 91 682 20 40
info@elixi-int.com
Reserved Area
Login
Register
Request Document
Send Document
Home
About Us
Services
Quality
News
Case Studies
Contact
Online Store
Let's talk
info@yourwebsite.com
+1 (555) 123-4567
Search
olaparib
9 January 2020
Lynparza (olaparib), already licensed for breast and ovarian cancer,it’s set to become the world’s first precision medicine for prostate cancer.
by Elixi